SCHEMBL8093113

SCHEMBL8093113

O=C(CCCCc1ccc(Cl)cc1)N1CC=C(c2ccc(F)cc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 1/20 0.53
▸ SIGMAR1 Q99720 5/20 0.53
▸ CNR1 P21554 1/20 0.52
▸ PARP1 P09874 3/20 0.50
▸ PARP2 Q9UGN5 1/20 0.48
▸ MAPT P10636 3/20 0.48
▸ LMNA P02545 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ NAAA Q02083 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8092621 0.94 CNR1 (0.57) DRD2SIGMAR1CNR1MAPTLMNA
SCHEMBL4074980 0.80 MEN1 (0.65) DRD2SIGMAR1CNR1PARP1PARP2
SCHEMBL8091484 0.75 DRD2 (0.55) DRD2MEN1KMT2ANAAA
SCHEMBL14224507 0.74 MAPK1 (0.58) SIGMAR1CNR1PARP1PARP2MAPT
SCHEMBL9557044 0.73 NAAA (0.54) NAAA
SCHEMBL10670972 0.73 MAPT (0.53) DRD2SIGMAR1CNR1PARP1MAPT
SCHEMBL9557028 0.73 NAAA (0.58) MAPTMEN1KMT2ANAAA
SCHEMBL8084492 0.73 TRPV1 (0.60) NAAANPC1
SCHEMBL8097277 0.73 HPGD (0.63) HTTNPSR1MEN1KMT2ANAAA
Hydrochloric Acid SCHEMBL10413762 0.73 NAAA (0.59) NAAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 — — US claimed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 — — EP claimed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 — — WO claimed
US-6057371-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, GASTROINTESTINAL DISORDERS, DRUG ABUSE, ANGINA, MIGRAINE, HYPERTENSION AND DEPRESSION VIRGINIA COMMONWEALTH UNIVERSITY (US) 2000-05-02 — — US disclosed
EP-0591426-A1 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1994-04-13 — — EP disclosed
WO-1993000313-A2 SIGMA RECEPTOR LIGANDS AND THE USE THEREOF VIRGINIA COMMONWEALTH UNIVERSITY (US) 1993-01-07 — — WO disclosed
Send feedback